KPIs & Operating Metrics(New)
Breakdown Of AssetsCost Of RevenueDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income Tax By RegionOpex As A % Of Total Revenue %OPEX SegregationProduct Revenue By CategoryProduct Revenue By Category AnnualProfitabilityProfitability %Profitability AnnualProfitability Annual %Property And Equipment BreakdownPurchase And Other CommitmentsRevenue By GeographyRevenue By Geography %Revenue By Major CustomersRevenue By Major Customers %Revenue By Major Customers AnnualRevenue By Major Customers Annual %Revenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) Cost Of Revenue: 2018-2024

Historic Cost of Revenue for Dynavax Technologies (DVAX) over the last 7 years, with Dec 2024 value amounting to $49.4 million.

  • Dynavax Technologies' Cost of Revenue rose 10.08% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.6 million, marking a year-over-year increase of 24.36%. This contributed to the annual value of $49.4 million for FY2024, which is 1.44% down from last year.
  • Latest data reveals that Dynavax Technologies reported Cost of Revenue of $49.4 million as of FY2024, which was down 1.44% from $50.2 million recorded in FY2023.
  • Dynavax Technologies' 5-year Cost of Revenue high stood at $262.2 million for FY2022, and its period low was $11.4 million during FY2020.
  • Moreover, its 3-year median value for Cost of Revenue was $50.2 million (2023), whereas its average is $120.6 million.
  • In the last 5 years, Dynavax Technologies' Cost of Revenue soared by 1,421.23% in 2021 and then slumped by 80.86% in 2023.
  • Dynavax Technologies' Cost of Revenue (Yearly) stood at $11.4 million in 2020, then surged by 1,421.23% to $173.6 million in 2021, then spiked by 51.03% to $262.2 million in 2022, then slumped by 80.86% to $50.2 million in 2023, then decreased by 1.44% to $49.4 million in 2024.